Key Development Growing scientific evidence suggests that frequent consumption of ultra-processed foods (UPFs) may alter the gut microbiome, influence immune... Read more
Category: Uncategorized
NEXT-GENERATION IMMUNOTHERAPY OFFERS NEW HOPE FOR CHILDREN WITH AGGRESSIVE BRAIN TUMORS
Key Development Early clinical findings have delivered a promising milestone in pediatric oncology, with three children diagnosed with aggressive brain... Read more
VIETNAM’S 100-DAY DIGITAL HEALTH RECORD CAMPAIGN LAYS THE FOUNDATION FOR A DATA-DRIVEN HEALTHCARE SYSTEM
Key Development Vietnam has launched a nationwide 100-day campaign to establish and update Electronic Health Records (EHRs) through the VNeID... Read more
DA NANG STRENGTHENS REGIONAL HEALTHCARE CAPACITY WITH A NEW VND 500 BILLION SPECIALIST HOSPITAL
Key Development Da Nang is advancing its healthcare infrastructure with plans for a new VND 500 billion specialist hospital in... Read more
ALLEGED CLINICAL MISCONDUCT AT A PRIVATE CLINIC UNDERSCORES THE GROWING IMPORTANCE OF CLINICAL GOVERNANCE IN VIETNAM’S HEALTHCARE SECTOR
Key Development A medical incident involving a private clinic in Vietnam has drawn widespread public attention after allegations that a... Read more
FDA PANEL BACKS BROADER COMPOUNDING ACCESS FOR BPC-157 IN LANDMARK PEPTIDE DECISION
Key Development A U.S. Food and Drug Administration (FDA) advisory committee has voted to recommend placing BPC-157 on the agency's... Read more
MERCK EXPANDS GLOBAL HIV ACCESS STRATEGY WITH LICENSING DEALS ACROSS 129 COUNTRIES
Key Development Merck has significantly expanded its global access strategy by signing seven voluntary licensing agreements that will allow generic... Read more
GE HEALTHCARE CFO TO STEP DOWN AS COMPANY REAFFIRMS STRONG BUSINESS MOMENTUM
Key Development GE HealthCare has announced that Chief Financial Officer Jay Saccaro will step down to pursue an opportunity outside... Read more
ASTRAZENECA FACES A CRUCIAL TEST AFTER CAMIZESTRANT SETBACK SHAKES INVESTOR CONFIDENCE
Key Development AstraZeneca is facing renewed scrutiny after late-stage clinical trial results for camizestrant, one of its most closely watched... Read more









